Social justicefromCornell Chronicle4 months agoMore diverse investigators could help diversify clinical trials | Cornell ChronicleBlack Americans trust Black doctors more in medical studies, leading to better enrollment in clinical trials.
Alternative medicinefromTheregister4 months agoMan with artificial heart survives 100 days outside hospitalBiVACOR's Total Artificial Heart successfully supported a patient for over 100 days before he received a transplant.
Alternative medicinefromwww.aljazeera.com4 months agoHow close are scientists to producing artificial blood?Artificial blood substitutes are being developed to address global blood shortages and improve transfusion safety.
Roam ResearchfromNature4 months agoRestoring vision with optogeneticsRobin McCoy is participating in a clinical trial for optogenetic therapy to combat her inherited retinitis pigmentosa.
European startupsfromSilicon Canals4 months agoFinland's Valo Therapeutics bags 19M in fundingValo Therapeutics raises â¬19M for innovative immunotherapy development targeting cancer with a novel technology.
Tech industryfromHackernoon4 months agoInside the Incredible Potential of Quantum Computing in Drug Development | HackerNoonQuantum computing has the potential to significantly accelerate drug development timelines, ultimately saving lives and reducing costs.
Social justicefromCornell Chronicle4 months agoMore diverse investigators could help diversify clinical trials | Cornell ChronicleBlack Americans trust Black doctors more in medical studies, leading to better enrollment in clinical trials.
Alternative medicinefromTheregister4 months agoMan with artificial heart survives 100 days outside hospitalBiVACOR's Total Artificial Heart successfully supported a patient for over 100 days before he received a transplant.
Alternative medicinefromwww.aljazeera.com4 months agoHow close are scientists to producing artificial blood?Artificial blood substitutes are being developed to address global blood shortages and improve transfusion safety.
Roam ResearchfromNature4 months agoRestoring vision with optogeneticsRobin McCoy is participating in a clinical trial for optogenetic therapy to combat her inherited retinitis pigmentosa.
European startupsfromSilicon Canals4 months agoFinland's Valo Therapeutics bags 19M in fundingValo Therapeutics raises â¬19M for innovative immunotherapy development targeting cancer with a novel technology.
Tech industryfromHackernoon4 months agoInside the Incredible Potential of Quantum Computing in Drug Development | HackerNoonQuantum computing has the potential to significantly accelerate drug development timelines, ultimately saving lives and reducing costs.